AU2259999A - Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation - Google Patents

Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Info

Publication number: AU2259999A
Authority: AU; Australia
Prior art keywords: hepatic; oxygenation; reversal; aging; prevention
Prior art date: 1998-01-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU22599/99A

Inventor

David George Le Couteur

Allan Joseph Mclean

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-30

Filing date

1999-02-01

Publication date

1999-08-16

1998-01-30 Priority claimed from AUPP1542A external-priority patent/AUPP154298A0/en

1998-12-09 Priority claimed from AUPP7619A external-priority patent/AUPP761998A0/en

1998-12-11 Priority claimed from AUPP7701A external-priority patent/AUPP770198A0/en

1999-02-01 Application filed by Individual filed Critical Individual

1999-02-01 Priority to AU22599/99A priority Critical patent/AU2259999A/en

1999-02-01 Priority claimed from PCT/AU1999/000065 external-priority patent/WO1999038507A1/en

1999-08-16 Publication of AU2259999A publication Critical patent/AU2259999A/en

Status Abandoned legal-status Critical Current

Links

230000032683 aging Effects 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
210000002767 hepatic artery Anatomy 0.000 title 1
230000002440 hepatic effect Effects 0.000 title 1
238000006213 oxygenation reaction Methods 0.000 title 1
230000002265 prevention Effects 0.000 title 1
229940124549 vasodilator Drugs 0.000 title 1
239000003071 vasodilator agent Substances 0.000 title 1

AU22599/99A 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation Abandoned AU2259999A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU22599/99A AU2259999A (en)	1998-01-30	1999-02-01	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
AUPP1542A AUPP154298A0 (en)	1998-01-30	1998-01-30	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP1542		1998-01-30
AUPP7619A AUPP761998A0 (en)	1998-12-09	1998-12-09	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AUPP7619		1998-12-09
AUPP7701A AUPP770198A0 (en)	1998-12-11	1998-12-11	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AUPP7701		1998-12-11
AU22599/99A AU2259999A (en)	1998-01-30	1999-02-01	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
PCT/AU1999/000065 WO1999038507A1 (en)	1998-01-30	1999-02-01	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Publications (1)

Publication Number	Publication Date
AU2259999A true AU2259999A (en)	1999-08-16

Family

ID=27422725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU22599/99A Abandoned AU2259999A (en)	1998-01-30	1999-02-01	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Country Status (1)

Country	Link
AU (1)	AU2259999A (en)

1999
- 1999-02-01 AU AU22599/99A patent/AU2259999A/en not_active Abandoned

Similar Documents

Publication	Publication Date	Title
IL141403A0 (en)	2002-03-10	Deleted adenoviruses and methods of making and administering the same
AU1606900A (en)	2000-05-29	Non-electrolytic gold plating compositions and methods of use thereof
AU1920900A (en)	2000-06-26	Solid water treatment composition and methods of preparation and use
IL183948A0 (en)	2007-10-31	Conjugates of peg-urate oxidase and use thereof
PL342892A1 (en)	2001-07-16	Remineralization of teeth
HUP0002493A3 (en)	2001-09-28	Use of colchinol derivatives as vascular damaging agents and certain new compounds
EP1076547A4 (en)	2001-09-26	Derivatives of arabinogalactan and compositions including the same
HUP0000963A3 (en)	2000-10-30	The use of levobupivacaine in paediatric surgery
AU3622600A (en)	2000-09-28	Metalloproteinases and methods of use therefor
AU3118499A (en)	1999-10-25	Soft tissue reconstructor and method of use
AU2001257406A1 (en)	2001-11-07	Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
IL138672A0 (en)	2001-10-31	Liposomal bupivacaine compositions and methods of preparation
AU3671999A (en)	1999-11-23	Combination of main scrubbing machine and attachment scrubbing machine
AU2600499A (en)	1999-08-30	Methods and compositions comprising the use of blocked b-amyloid peptide
AU3774100A (en)	2000-10-16	Heat-activated cleaning compositions with wrinkle-resistance and methods of use
AU7277798A (en)	1998-11-24	Use of sialyl galactosides and related compounds as anti-angiogenic agents
EP1088054A4 (en)	2003-05-07	GENES OF BIOSYNTHESIS AND METABOLISM OF CAROTENOID AND TECHNIQUES OF USE
AU6412599A (en)	2000-04-26	Oxybutynin formulations and methods of use
IL137836A0 (en)	2001-10-31	Methods and compositions for diagnosis of hepatoma
AU2259999A (en)	1999-08-16	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP154298A0 (en)	1998-02-19	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AU2987999A (en)	1999-09-20	Toothpaste and mouth rinse compositions
AU5226798A (en)	1998-06-29	Use of paracetamol as depigmenting agent
AUPP761998A0 (en)	1999-01-14	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AUPP770198A0 (en)	1999-01-14	Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation

Legal Events

Date	Code	Title	Description
2000-10-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase